Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Bayer HealthCare and Johnson & Johnson are facing a growing multidistrict litigation (MDL), consisting of numerous claims each alleging Xarelto hemorrhage. One of the most recent additions comes from a grieving widower, alleging his wife’s death was directly caused by uncontrollable Xarelto hemorrhage.
Florida plaintiff Howard R. is filing this Xarelto hemorrhage lawsuit on behalf of his deceased wife Selma R., alleging her death was caused by Xarelto hemorrhage.
According to Howard’s Xarelto lawsuit, Selma was prescribed the new generation anticoagulant in 2014 for blood clot prevention. This is a typical treatment purpose of Xarelto, which is also popularly prescribed to patients with atrial fibrillation and who are at high risk for stroke. Xarelto and other anticoagulants work by inhibiting the body’s clotting mechanism to increase ease and efficiency in the body’s circulation process.
However, this treatment mechanism also puts patients at risk for uncontrollable Xarelto hemorrhage because the body is less able to heal itself from minor internal bleeding wounds. This is reportedly what happened to Selma on Jan. 10, 2016, who had been admitted to the emergency room for cerebral brain hemorrhage.
Even with emergency medical intervention, Selma still died from her injuries, leaving her husband to later discover about the risks of Xarelto hemorrhage. Selma’s doctors confirmed this by ordering her to stop taking Xarelto at the time of her hospital admittance, which spurred Howard to file legal action on her behalf.
Overview of Xarelto Hemorrhage Allegations
At the time Selma was prescribed Xarelto, the medication was recommended to her based on the advertisements presented by the manufacturing companies Johnson & Johnson and Bayer HealthCare.
The pharmaceutical companies had reportedly emphasized the drug’s benefits while downplaying the potential risks, which ultimately resulted in Selma agreeing to take the drug, this Xarelto hemorrhage lawsuit claims.
Among the benefits listed in Xarelto literature were its efficiency and its single dose prescription feature, which is highly convenient compared to its older counterpart, warfarin. Even though warfarin patients have to undergo frequent doctor appointments for dose adjustments, warfarin patients have an easily accessible excessive bleeding antidote in the form of vitamin K.
Before the release of Praxbind in 2015, warfarin was the only well known anticoagulant with a reversal agent to treat internal bleeding. Praxbind was specifically released as a reversal agent for Pradaxa, which was released a year before Xarelto in 2010.
It is important to note that Pradaxa was the first anticoagulant medication to be released in this new group of anticoagulants since warfarin in the 1950s. This may have spurred other pharmaceutical companies to try their hand in the blood thinner market. However, new generation anticoagulants lacked a bleeding antidote, which has allegedly resulted in the deaths of numerous patients.
Howard’s Xarelto hemorrhage lawsuit is joining MDL No. 2592, where it will stand alongside other claims also alleging Xarelto hemorrhage. By joining an MDL, Howard’s claim will be streamlined through the litigation process and will avoid potential problems like conflicting rulings from different judges.
Howard states Selma would not have agreed to take the medication if she had known the risk of uncontrollable Xarelto hemorrhage. Howard’s Xarelto hemorrhage lawsuit is seeking multiple damages from the pharmaceutical companies including wrongful death, negligence and failure to warn.
This Xarelto Hemorrhage Lawsuit is Case No. 2:18-cv-00190-EEF-MBN, in the U.S. District Court for the Eastern District of Louisiana.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Xarelto attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Xarelto class action lawsuit is best for you. [In general, Xarelto lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
Get Help – It’s Free
Join a Free Xarelto Class Action Lawsuit Investigation
If you or a loved one took Xarelto (rivaroxaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, deep vein thrombosis or pulmonary embolism, you may have a legal claim. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Please Note:Â If you want to participate in this investigation, it is imperative that you reply to the law firm if they call or email you. Failing to do so may result in you not getting signed up as a client, if you qualify, or getting you dropped as a client.
Oops! We could not locate your form.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.